A review of recent FDG-PET studies on Alzheimer' s disease; for application to health insurance-covered medicine

Hiroyasu Ishikawa; E. Nakata; M. Kasuya; H. Ishii; K. Meguro

A review of recent FDG-PET studies on Alzheimer' s disease; for application to health insurance-covered medicine

Hiroyasu Ishikawa, E. Nakata, M. Kasuya, H. Ishii, K. Meguro

New Industry Creation Hatchery Center (NICHe)

Research output: Contribution to journal › Review article › peer-review

Abstract

Alzheimer's disease (AD) is the most common disease in dementia practice. According to a recent community-based study, the prevalence of dementia was 8.5% and 60% of dementia subjects were suffering from AD. Since there is no evidence on primary prevention for AD, secondary and tertiary prevention including making early diagnosis and treatment should be emphasized. (18) F-FDG PET is considered to be a prominent modality in early diagnosis of AD with regard to high sensitivity and specificity. However the diagnosis of AD using FDG-PET was not covered by the national health insurance in Japan. In this article, recent FDG-PET studies on AD were reviewed.

Original language	English
Pages (from-to)	425-431
Number of pages	7
Journal	Japanese Journal of Clinical Radiology
Volume	52
Issue number	3
Publication status	Published - 2007

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'A review of recent FDG-PET studies on Alzheimer' s disease; for application to health insurance-covered medicine'. Together they form a unique fingerprint.

Cite this

@article{346932bd88ad42078f8d36bd289fc3fa,

title = "A review of recent FDG-PET studies on Alzheimer' s disease; for application to health insurance-covered medicine",

abstract = "Alzheimer's disease (AD) is the most common disease in dementia practice. According to a recent community-based study, the prevalence of dementia was 8.5% and 60% of dementia subjects were suffering from AD. Since there is no evidence on primary prevention for AD, secondary and tertiary prevention including making early diagnosis and treatment should be emphasized. (18) F-FDG PET is considered to be a prominent modality in early diagnosis of AD with regard to high sensitivity and specificity. However the diagnosis of AD using FDG-PET was not covered by the national health insurance in Japan. In this article, recent FDG-PET studies on AD were reviewed.",

author = "Hiroyasu Ishikawa and E. Nakata and M. Kasuya and H. Ishii and K. Meguro",

year = "2007",

language = "English",

volume = "52",

pages = "425--431",

journal = "Japanese Journal of Clinical Radiology",

issn = "0009-9252",

publisher = "Kanehara Shuppan Co. Ltd",

number = "3",

}

TY - JOUR

T1 - A review of recent FDG-PET studies on Alzheimer' s disease; for application to health insurance-covered medicine

AU - Ishikawa, Hiroyasu

AU - Nakata, E.

AU - Kasuya, M.

AU - Ishii, H.

AU - Meguro, K.

PY - 2007

Y1 - 2007

N2 - Alzheimer's disease (AD) is the most common disease in dementia practice. According to a recent community-based study, the prevalence of dementia was 8.5% and 60% of dementia subjects were suffering from AD. Since there is no evidence on primary prevention for AD, secondary and tertiary prevention including making early diagnosis and treatment should be emphasized. (18) F-FDG PET is considered to be a prominent modality in early diagnosis of AD with regard to high sensitivity and specificity. However the diagnosis of AD using FDG-PET was not covered by the national health insurance in Japan. In this article, recent FDG-PET studies on AD were reviewed.

AB - Alzheimer's disease (AD) is the most common disease in dementia practice. According to a recent community-based study, the prevalence of dementia was 8.5% and 60% of dementia subjects were suffering from AD. Since there is no evidence on primary prevention for AD, secondary and tertiary prevention including making early diagnosis and treatment should be emphasized. (18) F-FDG PET is considered to be a prominent modality in early diagnosis of AD with regard to high sensitivity and specificity. However the diagnosis of AD using FDG-PET was not covered by the national health insurance in Japan. In this article, recent FDG-PET studies on AD were reviewed.

UR - http://www.scopus.com/inward/record.url?scp=34047276459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047276459&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:34047276459

VL - 52

SP - 425

EP - 431

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 3

ER -